文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

SWI/SNF ATP酶沉默的HLF增强实体癌的肺转移。

SWI/SNF ATPase silenced HLF potentiates lung metastasis in solid cancers.

作者信息

Zhou Jin, Hepperla Austin, Simon Jeremy M, Kim Kangsan, Hu Qing, Zhang Chuanhai, Dong Lei, Hu Lianxin, Zhang Cheng, Liao Chengheng, Fang Alice, Adachi Yayoi, Fu Haoyong, Wang Tao, Liang Qian, Zhao Fangzhou, Liu Hongyi, Takeda Masashi, Fang Jun, Zhong Hua, Ly Peter, Wang Lu, Kapur Payal, Xu Lin, Jia Liwei, Malladi Srinivas, Brugarolas James, Simon M Celeste, Li Bo, Zhang Qing

机构信息

Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX, USA.

Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel Hill, NC, USA.

出版信息

Nat Commun. 2025 Jun 5;16(1):5226. doi: 10.1038/s41467-025-60329-9.


DOI:10.1038/s41467-025-60329-9
PMID:40473600
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12141477/
Abstract

Metastasis is the main cause of cancer-related deaths, yet the underlying mechanisms remain elusive. Here, using clear cell renal cell carcinoma (ccRCC), a tumor type with frequent lung metastases, we conduct an in vivo genome-wide CRISPR-Cas9 screen and identify HLF as a potent suppressor of lung metastasis. HLF depletion enhances ccRCC cell migration and lung metastasis, whereas HLF overexpression abrogates these effects. In ccRCC patients, HLF expression is reduced at metastatic sites and associates with epigenetic silencing mediated by the SWI/SNF ATPase subunit BRG1. HLF levels negatively correlate with migration potential in collagen. Mechanistically, HLF regulates LPXN expression, modulating the integration of collagen's mechanical cues with the actin cytoskeleton through Paxillin, thereby suppressing cancer cell migration and lung metastasis. Overexpression of HLF or pharmacological inhibition of BRG1 reduces cell invasion across multiple cancer types. Our findings suggest that targeting the BRG1-HLF axis offers a promising therapeutic strategy for combating metastatic cancers.

摘要

转移是癌症相关死亡的主要原因,但其潜在机制仍不清楚。在这里,我们使用透明细胞肾细胞癌(ccRCC)——一种经常发生肺转移的肿瘤类型,进行了一项全基因组体内CRISPR-Cas9筛选,并确定HLF是肺转移的有效抑制因子。HLF缺失增强了ccRCC细胞的迁移和肺转移,而HLF过表达则消除了这些作用。在ccRCC患者中,HLF在转移部位的表达降低,并与由SWI/SNF ATP酶亚基BRG1介导的表观遗传沉默相关。HLF水平与胶原蛋白中的迁移潜能呈负相关。从机制上讲,HLF调节LPXN的表达,通过桩蛋白调节胶原蛋白的机械信号与肌动蛋白细胞骨架的整合,从而抑制癌细胞的迁移和肺转移。HLF的过表达或BRG1的药理学抑制可减少多种癌症类型的细胞侵袭。我们的研究结果表明,靶向BRG1-HLF轴为对抗转移性癌症提供了一种有前景的治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4737/12141477/64eeb569dc83/41467_2025_60329_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4737/12141477/2eb9ab2f6f5d/41467_2025_60329_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4737/12141477/897b69c6f15c/41467_2025_60329_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4737/12141477/787922952671/41467_2025_60329_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4737/12141477/020c769d17c1/41467_2025_60329_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4737/12141477/87fbd3c49ef2/41467_2025_60329_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4737/12141477/a8e8a9ed7a40/41467_2025_60329_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4737/12141477/64eeb569dc83/41467_2025_60329_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4737/12141477/2eb9ab2f6f5d/41467_2025_60329_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4737/12141477/897b69c6f15c/41467_2025_60329_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4737/12141477/787922952671/41467_2025_60329_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4737/12141477/020c769d17c1/41467_2025_60329_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4737/12141477/87fbd3c49ef2/41467_2025_60329_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4737/12141477/a8e8a9ed7a40/41467_2025_60329_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4737/12141477/64eeb569dc83/41467_2025_60329_Fig7_HTML.jpg

相似文献

[1]
SWI/SNF ATPase silenced HLF potentiates lung metastasis in solid cancers.

Nat Commun. 2025-6-5

[2]
Degron mediated BRM/SMARCA2 depletion uncovers novel combination partners for treatment of BRG1/SMARCA4-mutant cancers.

Biochem Biophys Res Commun. 2018-12-4

[3]
A synthetic lethality-based strategy to treat cancers harboring a genetic deficiency in the chromatin remodeling factor BRG1.

Cancer Res. 2013-7-19

[4]
SMARCA4/BRG1 deficiency induces a targetable dependence on oxidative phosphorylation in clear cell renal cell carcinoma.

Carcinogenesis. 2025-1-20

[5]
Tumor infiltrating T-cells and loss of expression of SWI/SNF genes in varying stages of clear cell renal cell carcinoma.

Pathol Res Pract. 2025-2

[6]
High expression of SMARCA4 or SMARCA2 is frequently associated with an opposite prognosis in cancer.

Sci Rep. 2018-2-1

[7]
Oncogenesis caused by loss of the SNF5 tumor suppressor is dependent on activity of BRG1, the ATPase of the SWI/SNF chromatin remodeling complex.

Cancer Res. 2009-10-15

[8]
MAX inactivation in small cell lung cancer disrupts MYC-SWI/SNF programs and is synthetic lethal with BRG1.

Cancer Discov. 2013-12-20

[9]
VHL mutation-mediated SALL4 overexpression promotes tumorigenesis and vascularization of clear cell renal cell carcinoma via Akt/GSK-3β signaling.

J Exp Clin Cancer Res. 2020-6-8

[10]
Long noncoding RNA CPS1-IT1 suppresses melanoma cell metastasis through inhibiting Cyr61 via competitively binding to BRG1.

J Cell Physiol. 2019-5-20

本文引用的文献

[1]
ChIP-Atlas 3.0: a data-mining suite to explore chromosome architecture together with large-scale regulome data.

Nucleic Acids Res. 2024-7-5

[2]
Epigenetic control of circadian clocks by environmental signals.

Trends Cell Biol. 2024-12

[3]
Tensin 1 regulated by hepatic leukemia factor represses the progression of prostate cancer.

Mutagenesis. 2023-12-19

[4]
HLF promotes ovarian cancer progression and chemoresistance via regulating Hippo signaling pathway.

Cell Death Dis. 2023-9-14

[5]
Collagen code in tumor microenvironment: Functions, molecular mechanisms, and therapeutic implications.

Biomed Pharmacother. 2023-10

[6]
G Protein-Coupled Receptor 56 Characterizes CTLs and Reflects the Progression of Lung Cancer Patients.

J Immunol. 2023-8-15

[7]
Pan-cancer whole-genome comparison of primary and metastatic solid tumours.

Nature. 2023-6

[8]
FilamentSensor 2.0: An open-source modular toolbox for 2D/3D cytoskeletal filament tracking.

PLoS One. 2023

[9]
Cell Competition Shapes Metastatic Latency and Relapse.

Cancer Discov. 2023-1-9

[10]
Nanoscale Tracking Combined with Cell-Scale Microrheology Reveals Stepwise Increases in Force Generated by Cancer Cell Protrusions.

Nano Lett. 2022-9-28

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索